Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx

American Journal of Surgery

Volumn 172, Issue 6, 1996, Pages 671-673

  Jahnke, Volker ^a   Matthias, Christoph ^a   Fryer, Antony ^b   Strange, Richard ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; GLUTATHIONE TRANSFERASE;

ADULT; ALLELISM; CIGARETTE SMOKING; CONFERENCE PAPER; ENZYME DEFECT; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX CANCER; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0030443106     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(96)00298-X     Document Type: Conference Paper

References (15)

1. Irish JC. Oncogenes in head and neck cancer: erb-B and ras oncogene activation in laryngeal carcinoma. In: Smee R, Bridger GP, eds. Laryngeal Cancer. Proceedings of the Second World Congress on Laryngeal Cancer, Sydney, Australia, February 20-24, 1994. New York: Elsevier; 1994:172.
2. Jahnke V. Bösartige tumoren des larynx. In: Naumnn HH, Helms J, Herberhold C, Kastenbauer E, eds. Oto-Rhino-Laryngologie in Klinik und Praxis. Vol 3. Hals, Stuttgart-New York: Georg Thieme Verlag; 1995:388.
3. Brugere J, Guenel P, Leclerc A, et al. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx and mouth. Cancer. 1986;57:391-395.
4. Heagerty AHM, Fitzgerald D, Smith A, et al. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet. 1994;343:266-268.
5. Pemble S, Schröder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterisation of the genetic polymorphism. Biochem J. 1994;300:271-276.
6. Strange RC. The glutathione S-transferase GSTM1 locus and cancer susceptibility. In: Tew K, Mannervik B, Mantle TJ, et al, eds. Structure and Function of Glutathione Transferases. Boca Raton, Florida: CRC Press; 1993:160.
7. Yengi L, Inskip A, Gilford J, et al. Polymorphism at the glutathione S-transferase, GSTM3 locus: interactions with cytochrome P 450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res. In press.
8. Brockmöller J, Kerb R, Drakoulis N, et al. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res. 1994;54:4103-4111.
9. Inskip A, Elexperu-Camiruaga J, Buxton N, et al. Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: rvidence for linkage with GSTM1*A. Biochem J. 1995;312:713-716.
10. Rannug A, Alexandrie AK, Persson I, et al. Genetic polymorphism of cytochromes 1A1, 2D6 and 2E1: regulation and toxicological significance. J Occup Environ Med. 1995;37:25-36.
11. Smith G, Stanley LA, Sim E, et al. Metabolic polymorphisms and cancer susceptibility. Cancer Surveys. 1995;25:27-65.
12. Nakachi K, Imai K, Hayashi S, et al. Polymorphisms of the CYP1A1 and glutathioneS-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 1993;53:2994-2999.
13. Warwick A, Sarhanis P, Redman C, et al. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis. 1994;15:2841-2845.
14. Trizna Z, Clayman GL, Spitz MR, et al. Glutathione S-transferase genotypes as risk factors for head and neck cancer. Am J Surg. 1995;170:499-501.
15. Henning S, Cascorbi I, Jahnke V, et al. Rapid arylamine-N-acetyltransferase (NAT2). A susceptibility factor for laryngeal cancer. Fourth International Conference on Head and Neck Cancer, Toronto, Ontario, 1996. Abstract.